We are hearing a LOT of chatter about a possible Xing-Plaxo merger in the $250 million range. The deal makes some sense - newly public Xing is headquartered in Germany and hasn’t gotten much traction in the U.S. where it competes directly with LinkedIn. Plaxo, with a very strong U.S. presence, could give them the opportunity they need to attack this market."
No comments:
Post a Comment